Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy

30 Jul 2025

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is now the most prevalent chronic liver disease worldwide, ranging from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. It poses a significant public health challenge. Growing evidence indicates that the gut microbiota plays a key role in the development and progression of NAFLD. Advances in sequencing technologies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, Metabolism, and Disease
Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40809055
DOI: 10.3389/fmicb.2025.1621583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategyPMID 40809055Read ↗

The gut microbiome and gut-liver axis in NAFLDSemantic proximity Read ↗

Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgerySemantic proximity Read ↗

Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read ↗

Gut Microbiota and Metabolite Dynamics in a MASLD-Associated Liver Fibrosis In Vivo Model: An Integrative Multi-Omic PerspectiveSemantic proximity Read ↗

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

The Role of the Intestinal Microbiota in Nonalcoholic SteatohepatitisSemantic proximity Read ↗

Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverSemantic proximity Read ↗

Deciphering the role of gut metabolites in non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.